Literature DB >> 26503660

A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.

Ana M Ocampo1, Liang Chen2, Astrid V Cienfuegos1, Gustavo Roncancio3, Kalyan D Chavda2, Barry N Kreiswirth2, J Natalia Jiménez4.   

Abstract

The global spread of carbapenem-resistant Klebsiella pneumoniae (CR-Kp) has been largely associated with sequence type 258 (ST258) and its related variants (clonal group 258 [CG258]). Here we describe the molecular epidemiology of CR-Kp from five tertiary care hospitals in Medellín, the second largest city in Colombia. All CR-Kp-infected patients admitted from June 2012 to June 2014 were included (n = 193). Patients' clinical information was obtained from medical records. Carbapenemase KPC, VIM, IMP, NDM, and OXA-48 genes were detected by PCR. A CG258-tonB79 cluster-specific real-time PCR (targeting the multilocus sequence type [MLST] tonB79 allele), pulsed-field gel electrophoresis (PFGE), and MLST analysis were performed for typing. Remarkably, 62.2% (n = 120) of isolates were from STs unrelated to CG258 (non-CG258). KPC-3 predominated in CG258 isolates (86.3%), while KPC-2 prevailed in non-CG258 isolates (75.5%) (P < 0.001). Multidrug resistance (MDR) frequency was significantly higher in CG258 strains (91.4% versus 56.1%; P < 0.001). ST512 (a single-locus variant of ST258) is the main ST in CG258 (96.3%), and isolates in this group showed closely related pulsotype and similar resistance gene profiles, suggesting the clonal spread of this strain. In contrast, high heterogeneity of STs (34/54), including eight novel STs, was found in non-CG258 isolates. Among non-CG258 isolates, ST14 (13.3%; n = 16) and ST307 (14.2%; n = 17) were the most frequent, and they showed distinct molecular and clinical characteristics in comparison to CG258 isolates. Our results suggest that the dissemination of carbapenem resistance in Medellín is due to heterogeneous K. pneumoniae clones, likely the result of horizontal transmission of KPC in different unrelated lineages, further highlighting the challenge in CR-Kp infection control and the need for a multifocal intervention.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26503660      PMCID: PMC4704171          DOI: 10.1128/AAC.01775-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  67 in total

1.  NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman.

Authors:  Laurent Poirel; Zaina Al Maskari; Fatma Al Rashdi; Sandrine Bernabeu; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2010-11-23       Impact factor: 5.790

2.  Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340).

Authors:  Polyana Silva Pereira; Carlos Felipe Machado de Araujo; Liliane Miyuki Seki; Viviane Zahner; Ana Paula D'Alincourt Carvalho-Assef; Marise Dutra Asensi
Journal:  J Antimicrob Chemother       Date:  2012-10-15       Impact factor: 5.790

3.  Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.

Authors:  Brenda M Brennan; Joseph R Coyle; Dror Marchaim; Jason M Pogue; Martha Boehme; Jennie Finks; Anurag N Malani; Kerrie E VerLee; Bryan O Buckley; Noreen Mollon; Daniel R Sundin; Laraine L Washer; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

4.  Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.

Authors:  David van Duin; Federico Perez; Susan D Rudin; Eric Cober; Jennifer Hanrahan; Julie Ziegler; Raymond Webber; Jacqueline Fox; Pamela Mason; Sandra S Richter; Marianne Cline; Geraldine S Hall; Keith S Kaye; Michael R Jacobs; Robert C Kalayjian; Robert A Salata; Julia A Segre; Sean Conlan; Scott Evans; Vance G Fowler; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

5.  Multiplex real-time PCR for detection of an epidemic KPC-producing Klebsiella pneumoniae ST258 clone.

Authors:  Liang Chen; Kalyan D Chavda; José R Mediavilla; Yanan Zhao; Henry S Fraimow; Stephen G Jenkins; Michael H Levi; Tao Hong; Albert D Rojtman; Christine C Ginocchio; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

Review 6.  Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.

Authors:  Neil Woodford; Jane F Turton; David M Livermore
Journal:  FEMS Microbiol Rev       Date:  2011-03-01       Impact factor: 16.408

7.  The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp.

Authors:  Riza Durmaz; Baris Otlu; Fatih Koksal; Salih Hosoglu; Recep Ozturk; Yasemin Ersoy; Elif Aktas; Nafia Canan Gursoy; Ahmet Caliskan
Journal:  Jpn J Infect Dis       Date:  2009-09       Impact factor: 1.362

8.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.

Authors:  Diamantis P Kofteridis; Antonis Valachis; Dimitra Dimopoulou; Sofia Maraki; Athanasia Christidou; Elpis Mantadakis; George Samonis
Journal:  J Infect Chemother       Date:  2014-04-03       Impact factor: 2.211

9.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

10.  Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene.

Authors:  Gaelle Cuzon; Thierry Naas; HaVy Truong; Maria Virginia Villegas; Karin T Wisell; Yehuda Carmeli; Ana C Gales; Shiri Navon Venezia; John P Quinn; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

View more
  38 in total

Review 1.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

2.  Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.

Authors:  Elizabeth Diago-Navarro; Isabel Calatayud-Baselga; Donglei Sun; Camille Khairallah; Inderjit Mann; Amaia Ulacia-Hernando; Brian Sheridan; Meiqing Shi; Bettina C Fries
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

3.  Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.

Authors:  Jiayang Li; Jianan Ren; Weiping Wang; Gefei Wang; Guosheng Gu; Xiuwen Wu; Ying Wang; Mei Huang; Jieshou Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-14       Impact factor: 3.267

Review 4.  Population genomics of Klebsiella pneumoniae.

Authors:  Kelly L Wyres; Margaret M C Lam; Kathryn E Holt
Journal:  Nat Rev Microbiol       Date:  2020-02-13       Impact factor: 60.633

Review 5.  Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

6.  Dynamics of bla KPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity.

Authors:  Ana M Rada; Elsa De La Cadena; Carlos Agudelo; Cesar Capataz; Nataly Orozco; Cristian Pallares; An Q Dinh; Diana Panesso; Rafael Ríos; Lorena Diaz; Adriana Correa; Blake M Hanson; Maria V Villegas; Cesar A Arias; Eliana Restrepo
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

Review 7.  Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147.

Authors:  Gisele Peirano; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

8.  Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.

Authors:  David van Duin; Cesar A Arias; Lauren Komarow; Liang Chen; Blake M Hanson; Gregory Weston; Eric Cober; Omai B Garner; Jesse T Jacob; Michael J Satlin; Bettina C Fries; Julia Garcia-Diaz; Yohei Doi; Sorabh Dhar; Keith S Kaye; Michelle Earley; Andrea M Hujer; Kristine M Hujer; T Nicholas Domitrovic; William C Shropshire; An Dinh; Claudia Manca; Courtney L Luterbach; Minggui Wang; David L Paterson; Ritu Banerjee; Robin Patel; Scott Evans; Carol Hill; Rebekka Arias; Henry F Chambers; Vance G Fowler; Barry N Kreiswirth; Robert A Bonomo
Journal:  Lancet Infect Dis       Date:  2020-03-06       Impact factor: 25.071

9.  Genomic and Molecular Characterization of Clinical Isolates of Enterobacteriaceae Harboring mcr-1 in Colombia, 2002 to 2016.

Authors:  Sandra Yamile Saavedra; Lorena Diaz; Magdalena Wiesner; Adriana Correa; Stefany Alejandra Arévalo; Jinnethe Reyes; Andrea Melissa Hidalgo; Elsa de la Cadena; Marcela Perenguez; Lucy Angeline Montaño; Javier Ardila; Rafael Ríos; María Victoria Ovalle; Paula Díaz; Paola Porras; Maria V Villegas; Cesar A Arias; Mauricio Beltrán; Carolina Duarte
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

10.  An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the "Perfect Storm".

Authors:  Laura J Rojas; George M Weinstock; Elsa De La Cadena; Lorena Diaz; Rafael Rios; Blake M Hanson; Joseph S Brown; Purva Vats; Daniel S Phillips; Hoan Nguyen; Kristine M Hujer; Adriana Correa; Mark D Adams; Federico Perez; Erica Sodergren; Apurva Narechania; Paul J Planet; Maria V Villegas; Robert A Bonomo; Cesar A Arias
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.